Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial

NCT: NCT05975593 · RECRUITING

NCT IDNCT05975593
StatusRECRUITING
Start Date2024-01-11
Completion2032-12-31
SponsorWashington University School of Medicine (OTHER)
First posted
Last updated

Brief Summary

This study is a dynamically adjustable prospective longitudinal study designed to capture biospecimen (biopsy, blood, surgical) and multimodal treatment-related data (imaging, dosimetry, clinical) before, during, and after treatment with definitive-intent chemoradiotherapy for patients with locally advanced cervical and pancreatic cancer.

Frequently Asked Questions

What is MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial?

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial is a clinical trial registered under NCT05975593. Current status: RECRUITING.

What is the status of NCT05975593?

The current status of NCT05975593 (MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial) is: RECRUITING.

When did MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial start?

MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial started on 2024-01-11.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑